Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: Data from the SMART study (2009)

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 1992-1997

  Lascols, Christine ^a   Hackel, Meredith ^a   Marshall, Steven H ^b   Hujer, Andrea M ^c   Bouchillon, Sam ^a   Badal, Robert ^a   Hoban, Daryl ^a   Bonomo, Robert A ^b,c  

^a Division of Microbiology   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbapenemases; Enterobacteriaceae; Microarray analysis

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE KPC; BETA LACTAMASE NDM 1; BETA LACTAMASE OXA 48; BETA LACTAMASE VIM; CARBAPENEMASE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATE; DNA SEQUENCE; ENTEROBACTERIACEAE; GENE IDENTIFICATION; INDIA; MICROARRAY ANALYSIS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PREVALENCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENVIRONMENTAL MONITORING; GENETIC VARIATION; HUMANS; INDIA; MICROARRAY ANALYSIS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING;

EID: 80051695875     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr240     Document Type: Article

References (27)

1. Paterson DL, Bonomo RA. Extended-spectrum b-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
2. Deshpande P, Rodrigues C, Shetty A et al. New Delhi metallob-lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India 2010; 58: 147-9.
3. Bush K. Metallo-b-lactamases: a class apart. Clin Infect Dis 1998; 27 Suppl 1: S48-53.
4. Rasmussen BA, Bush K. Carbapenem-hydrolyzing b-lactamases. Antimicrob Agents Chemother 1997; 41: 223-32.
5. Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in anaerobes. Clin Infect Dis 1997; 24 Suppl 1: S110-20.
6. Bush K. Alarming b-lactamase-mediated resistance in multidrugresistant Enterobacteriaceae. Curr Opin Microbiol 2010; 13: 558-64.
7. Cuzon G, Naas T, Nordmann P. [KPC carbapenemases: what is at stake in clinical microbiology?]. Pathol Biol (Paris) 2010; 58: 39-45.
8. Endimiani A, Depasquale JM, Forero S et al. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009; 64: 1102-10.
9. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010; 65: 1119-25.
10. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010; 36 Suppl 3: S8-14.
11. Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-b-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 5046-54.
12. Bonomo RA. New Delhi metallo-b-lactamase and multidrug resistance: a global SOS? Clin Infect Dis 2011; 52: 485-7.
13. Moellering RC Jr. NDM-1-a cause for worldwide concern. N Engl J Med 2010; 363: 2377-9.
14. Walsh TR, Toleman MA. The new medical challenge: why NDM-1? Why Indian? Expert Rev Anti Infect Ther 2011; 9: 137-41.
15. Nordmann P, Carrer A. [Carbapenemases in Enterobacteriaceae]. Arch Pediatr 2010; 17 Suppl 4: S154-62.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20-U. CLSI, Wayne, PA, USA, 2010.
17. Endimiani A, Perez F, Bajaksouzian S et al. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. J Clin Microbiol 2010; 48: 4417-25.
18. Dallenne C, Da Costa A, Decre D et al. Development of a set of multiplex PCR assays for the detection of genes encoding important b-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010; 65: 490-5.
19. Yigit H, Queenan AM, Anderson GJ et al. Novel carbapenemhydrolyzing b-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-61.
20. Cohen Stuart J, Dierikx C, Al Naiemi N et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum b-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother 2010; 65: 1377-81.
21. Cambau E, Lascols C, Sougakoff W et al. Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005. Clin Microbiol Infect 2006; 12: 1013-20.
22. Castanheira M, Deshpande LM, Mathai D et al. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006- 2007. Antimicrob Agents Chemother 2010; 55: 1274-8.
23. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
24. Chen Y, Zhou Z, Jiang Y et al. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother 2011; 66: 1255-9.
25. Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 2010; 65: 2253-4.
26. Kaase M, Nordmann P, Wichelhaus TA et al. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother 2011; 66: 1260-2.
27. Walsh TR, Weeks J, Livermore DM et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11: 355-62.